Digital therapeutics using virtual reality‐based visual perceptual learning for visual field defects in stroke: A double‐blind randomized trial

Author:

Namgung Eun1,Kwon Sun U.2,Han Moon‐Ku3,Kim Gyeong‐Moon4,Kim Hahn Young5,Park Kwang‐Yeol6,Cho Moonju7,Choi Ha‐Gyun7,Nah Hyun‐Wook8,Lim Hyun Taek9,Kang Dong‐Wha27ORCID

Affiliation:

1. Asan Institute for Life Sciences Asan Medical Center Seoul South Korea

2. Department of Neurology, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

3. Department of Neurology Seoul National University Bundang Hospital, Seoul National University College of Medicine Seongnam South Korea

4. Department of Neurology, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul South Korea

5. Department of Neurology Konkuk University Medical Center, Konkuk University College of Medicine Seoul South Korea

6. Department of Neurology Chung‐Ang University Hospital, Chung‐Ang University College of Medicine Seoul South Korea

7. Nunaps Inc. Seoul South Korea

8. Department of Neurology Chungnam National University Sejong Hospital, Chungnam National University College of Medicine Sejong South Korea

9. Department of Ophthalmology, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

Abstract

AbstractIntroductionVisual field defects (VFDs) represent a debilitating poststroke complication, characterized by unseen parts of the visual field. Visual perceptual learning (VPL), involving repetitive visual training in blind visual fields, may effectively restore visual field sensitivity in cortical blindness. This current multicenter, double‐blind, randomized, controlled clinical trial investigated the efficacy and safety of VPL‐based digital therapeutics (Nunap Vision [NV]) for treating poststroke VFDs.MethodsStroke outpatients with VFDs (>6 months after stroke onset) were randomized into NV (defective field training) or Nunap Vision‐Control (NV‐C, central field training) groups. Both interventions provided visual perceptual training, consisting of orientation, rotation, and depth discrimination, through a virtual reality head‐mounted display device 5 days a week for 12 weeks. The two groups received VFD assessments using Humphrey visual field (HVF) tests at baseline and 12‐week follow‐up. The final analysis included those completed the study (NV, n = 40; NV‐C, n = 35). Efficacy measures included improved visual area (sensitivity ≥6 dB) and changes in the HVF scores during the 12‐week period.ResultsWith a high compliance rate, NV and NV‐C training improved the visual areas in the defective hemifield (>72 degrees2) and the whole field (>108 degrees2), which are clinically meaningful improvements despite no significant between‐group differences. According to within‐group analyses, mean total deviation scores in the defective hemifield improved after NV training (= .03) but not after NV‐C training (= .12).ConclusionsThe current trial suggests that VPL‐based digital therapeutics may induce clinically meaningful visual improvements in patients with poststroke VFDs. Yet, between‐group differences in therapeutic efficacy were not found as NV‐C training exhibited unexpected improvement comparable to NV training, possibly due to learning transfer effects.

Funder

National Research Foundation of Korea

Korea Health Industry Development Institute

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3